Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics- Double Blind Placebo Controlled Study
Phase 4
12 Years
20 Years
12 Years
20 Years
Not Enrolling
Both
Drug Induced Weight Gain
Both
Drug Induced Weight Gain
Trial Information
Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics- Double Blind Placebo Controlled Study
Inclusion Criteria:
- 12-20 year olds treated by atypical antipsychotics
- weight gain of more than 10% than expected for age
- Overweight of more than 10% than expected for age and height
Exclusion Criteria:
- Physical conditions requiring pharmacological treatment
- Changes in drug type or dosage 2 months before the trial, except for 25% changes in
dosage
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Weight loss
Outcome Time Frame:
12 weeks
Safety Issue:
No
Authority:
Israel: health Administration
Study ID:
Metformin-38CTIL
NCT ID:
NCT00845936
Start Date:
May 2009
Completion Date:
May 2010
Related Keywords:
- Drug Induced Weight Gain
- Atypical antipsychotics
- Weight
- adolecsents
- pediatric
- Metformin
- Weight Gain
Name | Location |
|---|
